文献速递胸部肿瘤放疗放疗物理与技术

MRI在早期肺癌诊断与治疗中的作用综述

A review of the role of MRI in diagnosis and treatment of early stage lung cancer.
PubMed 文献 · Clin Transl Radiat Oncol · 2020-06-06

本文综述MRI在早期肺癌诊断、分期与治疗中的应用价值。MRI软组织对比优于CT,但肺部与纵隔的物理特性带来独特挑战;扩散加权成像与动态增强MRI等功能序列在诊断和疗效评估中崭露头角,MR-linac推动的MR引导放疗在早期肺癌中展现初步潜力。

要点

  • 多排CT仍是肺部成像金标准,MRI技术进展提升其在早期肺癌的临床相关性。
  • 扩散加权MRI与动态增强MRI等功能成像可用于肺癌诊断与疗效评估。
  • MR-linac推动MR引导放疗整合,早期数据显示对早期肺癌治疗有潜力。

核心结论

  • MRI在早期肺癌的诊断与治疗中均是有前景的成像手段。

研究设计与样本

  • 本文为综述,总结MRI在早期肺癌诊断、分期与治疗中作用的文献。

主要发现

  • MRI软组织对比优于CT,但肺部与纵隔物理特性给肺MRI带来独特挑战。
  • 多排CT仍是肺部成像金标准,MRI技术进步使其在早期肺癌评估中临床相关性增加。
  • PET在该情境中使用更频繁,扩散加权MRI与动态增强MRI等功能MR正成为诊断与疗效评估的有用手段。
  • MR-linac的发展推动MRI以MR引导放疗形式整合进放疗实施。
  • 尽管MRgRT在早期肺癌放疗中存在挑战,使用MR-linac的早期数据显示治疗早期肺癌的潜力。

临床怎么用

  • 在早期肺癌评估中可将功能MRI(扩散加权、动态增强)作为诊断与疗效评估的补充手段。
  • 开展早期肺癌MR引导放疗可参考MR-linac的早期数据,但需认识其挑战。

局限性

  • 本文为综述,未报告原始研究的具体样本量、效应值或统计学指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite magnetic resonance imaging (MRI) being a mainstay in the oncologic care for many disease sites, it has not routinely been used in early lung cancer diagnosis, staging, and treatment. While MRI provides improved soft tissue contrast compared to computed tomography (CT), an advantage in multiple organs, the physical properties of the lungs and mediastinum create unique challenges for lung MRI. Although multi-detector CT remains the gold standard for lung imaging, advances in MRI technology have led to its increased clinical relevance in evaluating early stage lung cancer. Even though positron emission tomography is used more frequently in this context, functional MR imaging, including diffusion-weighted MRI and dynamic contrast-enhanced MRI, are emerging as useful modalities for both diagnosis and evaluation of treatment response for lung cancer. In parallel with these advances, the development of combined MRI and linear accelerator devices (MR-linacs), has spurred the integration of MRI into radiation treatment delivery in the form of MR-guided radiotherapy (MRgRT). Despite challenges for MRgRT in early stage lung cancer radiotherapy, early data utilizing MR-linacs shows potential for the treatment of early lung cancer. In both diagnosis and treatment, MRI is a promising modality for imaging early lung cancer.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Sim AJ, Kaza E, Singer L, et al. A review of the role of MRI in diagnosis and treatment of early stage lung cancer. Clin Transl Radiat Oncol. 2020. PMID: 32596518. doi:10.1016/j.ctro.2020.06.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。